The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

Meet the woman leading vaccine innovation in Senegal to fight Rift Valley fever and empower Africa’s next generation of ...

The latest guidance reduction was the second time in the last six months that the firm has revised its forecast in a negative ...

An exciting collaboration between the Ragon Institute and the Jameel Clinic at MIT has achieved a significant milestone in leveraging artificial intelligence (AI) to aid the development of T cell ...

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it's not robust enough.

Two animal deaths at Lincoln Park Zoo in Chicago have been traced to an outbreak of avian influenza, or bird flu, according to a statement from zoo officials on Wednesday. It also announced that ...